Annual Current Liabilities
$40.62 M
+$15.61 M+62.39%
December 31, 2023
Summary
- As of February 8, 2025, MRNS annual total current liabilities is $40.62 million, with the most recent change of +$15.61 million (+62.39%) on December 31, 2023.
- During the last 3 years, MRNS annual current liabilities has risen by +$29.89 million (+278.64%).
- MRNS annual current liabilities is now at all-time high.
Performance
MRNS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$34.50 M
-$1.36 M-3.80%
September 30, 2024
Summary
- As of February 8, 2025, MRNS quarterly total current liabilities is $34.50 million, with the most recent change of -$1.36 million (-3.80%) on September 30, 2024.
- Over the past year, MRNS quarterly current liabilities has stayed the same.
- MRNS quarterly current liabilities is now -19.30% below its all-time high of $42.76 million, reached on March 31, 2024.
Performance
MRNS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
MRNS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +62.4% | 0.0% |
| 3 y3 years | +278.6% | +37.9% |
| 5 y5 years | +488.0% | +37.9% |
MRNS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +62.4% | -19.3% | +76.6% |
| 5 y | 5-year | at high | +405.8% | -19.3% | +329.6% |
| alltime | all time | at high | +1892.3% | -19.3% | +2483.8% |
Marinus Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $34.50 M(-3.8%) |
| Jun 2024 | - | $35.87 M(-16.1%) |
| Mar 2024 | - | $42.76 M(+5.3%) |
| Dec 2023 | $40.62 M(+62.4%) | $40.62 M(+33.0%) |
| Sep 2023 | - | $30.55 M(+19.3%) |
| Jun 2023 | - | $25.60 M(+19.0%) |
| Mar 2023 | - | $21.51 M(-14.0%) |
| Dec 2022 | $25.02 M(-38.3%) | $25.02 M(+18.8%) |
| Sep 2022 | - | $21.05 M(-8.9%) |
| Jun 2022 | - | $23.11 M(+18.3%) |
| Mar 2022 | - | $19.54 M(-51.8%) |
| Dec 2021 | $40.57 M(+278.1%) | $40.57 M(+7.7%) |
| Sep 2021 | - | $37.68 M(+125.7%) |
| Jun 2021 | - | $16.69 M(+3.6%) |
| Mar 2021 | - | $16.12 M(+50.3%) |
| Dec 2020 | $10.73 M(+33.6%) | $10.73 M(+13.7%) |
| Sep 2020 | - | $9.44 M(-0.7%) |
| Jun 2020 | - | $9.50 M(-8.0%) |
| Mar 2020 | - | $10.32 M(+28.6%) |
| Dec 2019 | $8.03 M | $8.03 M(-6.3%) |
| Sep 2019 | - | $8.57 M(-6.9%) |
| Jun 2019 | - | $9.20 M(+37.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $6.68 M(-3.4%) |
| Dec 2018 | $6.91 M(+171.6%) | $6.91 M(+0.5%) |
| Sep 2018 | - | $6.88 M(+93.2%) |
| Jun 2018 | - | $3.56 M(+98.4%) |
| Mar 2018 | - | $1.79 M(-29.5%) |
| Dec 2017 | $2.54 M(-68.5%) | $2.54 M(+4.7%) |
| Sep 2017 | - | $2.43 M(-57.2%) |
| Jun 2017 | - | $5.67 M(-13.6%) |
| Mar 2017 | - | $6.57 M(-18.7%) |
| Dec 2016 | $8.08 M(+8.7%) | $8.08 M(-11.9%) |
| Sep 2016 | - | $9.18 M(-10.0%) |
| Jun 2016 | - | $10.20 M(+31.5%) |
| Mar 2016 | - | $7.75 M(+4.3%) |
| Dec 2015 | $7.43 M(+264.6%) | $7.43 M(+11.6%) |
| Sep 2015 | - | $6.66 M(+14.0%) |
| Jun 2015 | - | $5.85 M(+7.4%) |
| Mar 2015 | - | $5.45 M(+167.1%) |
| Dec 2014 | $2.04 M(-13.8%) | $2.04 M(+52.7%) |
| Sep 2014 | - | $1.34 M(-55.5%) |
| Jun 2014 | - | $3.00 M(+48.2%) |
| Mar 2014 | - | $2.03 M(-14.4%) |
| Dec 2013 | $2.37 M(-47.4%) | $2.37 M |
| Dec 2012 | $4.50 M | - |
FAQ
- What is Marinus Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals annual current liabilities year-on-year change?
- What is Marinus Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals quarterly current liabilities year-on-year change?
What is Marinus Pharmaceuticals annual total current liabilities?
The current annual current liabilities of MRNS is $40.62 M
What is the all time high annual current liabilities for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high annual total current liabilities is $40.62 M
What is Marinus Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, MRNS annual total current liabilities has changed by +$15.61 M (+62.39%)
What is Marinus Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of MRNS is $34.50 M
What is the all time high quarterly current liabilities for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high quarterly total current liabilities is $42.76 M
What is Marinus Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, MRNS quarterly total current liabilities has changed by $0.00 (0.00%)